SENORES PHARMACEUTICALS L (SENORES) Share Price hits fresh 52-week high at Rs 1,595
- August 24, 2026
- Posted by: Harsh Piplani
- Category: News
SENORES PHARMACEUTICALS L Share Price climbed to Rs 1,595 on 24 August 2026, up Rs 80.35 or 5.3% from the previous close, and set a fresh 52-week high. The company’s market capitalisation stood at Rs 6,975.51 crore. The move places SENORES PHARMACEUTICALS L Share Price Today in focus for market participants tracking SENORES PHARMACEUTICALS L Stock News, especially because the supplied data confirms the price event but does not establish a company-specific catalyst. Univest is tracking the stock as it trades at a yearly high and remains one of the more closely watched names in the Healthcare space today.
SENORES PHARMACEUTICALS L Share Price matched the day’s high at Rs 1,595 after opening at Rs 1,520.05 and touching a low of Rs 1,520. The stock closed the gap between the opening level and the session peak by the end of the current snapshot, with turnover at Rs 1.61 crore. For readers searching SENORES PHARMACEUTICALS L Share Price Today or SENORES PHARMACEUTICALS L Stock News, the verified takeaway is straightforward: the share price has reached a fresh one-year high, and the data points available here describe the price event rather than its cause. Univest highlights the move in the context of the company’s market cap, sector classification and valuation metrics.
SENORES PHARMACEUTICALS L Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,595 |
| Previous Close | Rs 1,514.65 |
| Today's Move | +Rs 80.35 (+5.3%) |
| Open | Rs 1,520.05 |
| High | Rs 1,595 |
| Low | Rs 1,520 |
| Turnover | Rs 1.61 crore |
| Market Capitalisation | Rs 6,975.51 crore |
SENORES PHARMACEUTICALS L (SENORES) traded at Rs 1,595 versus the previous close of Rs 1,514.65, a rise of 5.3%. The stock opened at Rs 1,520.05, reached a high of Rs 1,595 and touched a low of Rs 1,520.
SENORES PHARMACEUTICALS L Share Price opened at Rs 1,520.05, compared with the previous close of Rs 1,514.65, and moved to Rs 1,595 at the time of this snapshot. The intraday low was Rs 1,520, while the session high was Rs 1,595, which is also the fresh 52-week high. That places the stock at Rs 80.35 above the prior close, equal to a 5.3% rise. Turnover of Rs 1.61 crore shows the value of trades executed during the session, but it does not by itself explain why the move occurred.
For investors following SENORES PHARMACEUTICALS L Share Price Today, the important point is that the day’s best price aligned with the yearly high. The move is relevant because it changes the recent price reference point and keeps SENORES PHARMACEUTICALS L Share Price in the list of 52 Week High Stocks on the Indian stock market. Univest notes the event as a factual price milestone rather than a commentary on market behaviour or a corporate trigger.
SENORES PHARMACEUTICALS L (SENORES) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 6,975.51 crore |
| P/E Ratio | 55.2x |
| P/B Ratio | 7.24x |
| ROE | 11.78% |
| ROCE | 11.94% |
| EPS | Rs 27.44 |
| Book Value Per Share | Rs 209.33 |
| Dividend Yield | 0% |
SENORES PHARMACEUTICALS L (SENORES) fundamental metrics show P/E 55.2x, P/B 7.24x, ROE 11.78%, ROCE 11.94%. These figures provide context only and are not a buy or sell signal.
SENORES PHARMACEUTICALS L has a market capitalisation of Rs 6975.51 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 55.2x, P/B at 7.24x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 11.78% and ROCE of 11.94%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 27.44, book value per share of Rs 209.33, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 30.84x, median ROE of 11.81%, median ROCE of 13.68%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 55.2x |
| Benchmark Median P/E | 30.84x |
| Benchmark Average P/E | 46.28x |
| Benchmark P/E Range | 2.94x to 689.27x |
| Company P/B Ratio | 7.24x |
| Benchmark Median P/B | 2.57x |
| Company ROE | 11.78% |
| Benchmark Median ROE | 11.81% |
| Company ROCE | 11.94% |
| Benchmark Median ROCE | 13.68% |
| Company Market Capitalisation | Rs 6,975.51 crore |
| Benchmark Median Market Cap | Rs 506.13 crore |
SENORES PHARMACEUTICALS L (SENORES) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
SENORES PHARMACEUTICALS L (SENORES) has a P/E ratio of 55.2x, which is above the benchmark median of 30.84x, a difference of +78.99%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
SENORES PHARMACEUTICALS L (SENORES) has a ROE of 11.78%, which is below the benchmark median of 11.81%, a difference of -0.25%. SENORES PHARMACEUTICALS L (SENORES) has a ROCE of 11.94%, which is below the benchmark median of 13.68%, a difference of -12.72%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Aarti Pharmalabs Ltd. | AARTIPHARM | 7,404.91 | 34.74 | 3.38 | 14.55 | 17.59 |
| Supriya Lifescience Ltd. | SUPRIYA | 6,478.87 | 32.66 | 5.3 | 20.74 | 27.63 |
| Sanofi India Ltd. | SANOFI | 7,711.34 | 23.82 | 9.34 | 44.5 | 55.46 |
| Innova Captab Ltd. | INNOVACAP | 6,243.53 | 40.54 | 5.5 | 13.75 | 15.04 |
| Bliss GVS Pharma Ltd. | BLISSGVS | 6,187.87 | 45.44 | 5.02 | 12.11 | 17.4 |
SENORES PHARMACEUTICALS L (SENORES) has a P/E ratio of 55.2x compared with the displayed peer median of 34.74x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 11.78% compares with a peer median of 14.55% across the companies shown in the table. ROCE stood at 11.94% versus the displayed peer median of 17.59%, providing a capital-efficiency comparison. SENORES PHARMACEUTICALS L (SENORES) has a market capitalisation of Rs 6,975.51 crore. Among the 5 peers shown, 2 have a larger market capitalisation.
Why Investors Are Watching SENORES PHARMACEUTICALS L
- SENORES PHARMACEUTICALS L Share Price touched Rs 1,595, which is the fresh 52-week high in the latest snapshot.
- The stock rose Rs 80.35, or 5.3%, from the previous close of Rs 1,514.65.
- Market capitalisation stands at Rs 6,975.51 crore for SENORES PHARMACEUTICALS L Share Price.
- The company’s P/E ratio is 55.2 and its P/B ratio is 7.24, both above the industry medians in the supplied benchmark.
- Revenue and net profit both increased in the latest year-on-year figures shown in the supplied financial data.
About SENORES PHARMACEUTICALS L
SENORES PHARMACEUTICALS L Share Price belongs to the Healthcare sector and the Pharmaceuticals & Drugs industry. The supplied company profile identifies the stock under the NSE and BSE universe through the symbol SENORES and places it within a listed pharmaceutical business context. For SENORES PHARMACEUTICALS L Share Price Today readers, the main company facts available here are its sector classification, industry grouping and financial metrics. Univest keeps this profile section factual and concise, using only the supplied company and industry information.
Track SENORES PHARMACEUTICALS L Share Price on Univest
Use SENORES PHARMACEUTICALS L (SENORES) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Investors tracking SENORES PHARMACEUTICALS L Share Price on Univest can follow live share price updates, 52-week levels, valuation ratios, sector comparison, earnings data, and the shareholding pattern when available. Univest also brings together SENORES PHARMACEUTICALS L Stock News, company news, market cap and stock analysis in one place for quick review.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
What is SENORES PHARMACEUTICALS L Share Price today?
Ans. SENORES PHARMACEUTICALS L Share Price is Rs 1,595 in the latest snapshot. It is up Rs 80.35, or 5.3%, from the previous close of Rs 1,514.65 and has reached a fresh 52-week high.
Why did SENORES PHARMACEUTICALS L Share Price trend in news today?
Ans. The supplied data confirms a fresh 52-week high and a 5.3% rise to Rs 1,595. It does not establish a company-specific catalyst, so the article stays limited to the verified price event and valuation context.
What is the 52-week high for SENORES PHARMACEUTICALS L?
Ans. The fresh 52-week high for SENORES PHARMACEUTICALS L is Rs 1,595. The current session high matches that level, making it the latest yearly high in the supplied market data. The stock moved 5.3% during the session.
How is SENORES PHARMACEUTICALS L Share Price valued versus peers?
Ans. SENORES PHARMACEUTICALS L Share Price trades at a P/E of 55.2 and P/B of 7.24. Both are above the supplied industry medians and above the peer P/E range shown here.
What do the latest fundamentals show for SENORES PHARMACEUTICALS L?
Ans. The company reports market capitalisation of Rs 6,975.51 crore, EPS of Rs 27.44 and book value of Rs 209.33. Revenue and net profit both increased in the latest annual comparison provided.
How does SENORES PHARMACEUTICALS L compare on profitability?
Ans. ROE is 11.78% and ROCE is 11.94%. ROE is close to the industry median in the supplied benchmark, while ROCE is below the benchmark median and average. ROE stands at 11.78%.
Does SENORES PHARMACEUTICALS L pay a dividend yield?
Ans. The supplied dividend yield is 0. That means no dividend yield is reflected in the latest dataset, so readers should rely on the reported financial ratios and earnings figures for context.
Which sector and industry does SENORES PHARMACEUTICALS L belong to?
Ans. SENORES PHARMACEUTICALS L belongs to the Healthcare sector and the Pharmaceuticals & Drugs industry. The supplied benchmark covers 204 same-industry companies and 290 companies in the broader sector. The stock belongs to the Healthcare sector.
What should investors monitor in SENORES PHARMACEUTICALS L Share Price next?
Ans. Investors should monitor whether SENORES PHARMACEUTICALS L Share Price continues to trade around the fresh 52-week high, along with future earnings, valuation ratios and the sector benchmark context already supplied.
